These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9652824)

  • 1. A peptide-binding assay for the disease-associated HLA-DQ8 molecule.
    Straumfors A; Johansen BH; Vartdal F; Sollid LM; Thorsby E; Buus S
    Scand J Immunol; 1998 Jun; 47(6):561-7. PubMed ID: 9652824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(alpha 1*0501, beta 1*0201) molecule.
    Johansen BH; Buus S; Vartdal F; Viken H; Eriksen JA; Thorsby E; Sollid LM
    Int Immunol; 1994 Mar; 6(3):453-61. PubMed ID: 8186196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).
    Godkin A; Friede T; Davenport M; Stevanovic S; Willis A; Jewell D; Hill A; Rammensee HG
    Int Immunol; 1997 Jun; 9(6):905-11. PubMed ID: 9199974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.
    Zhou Z; Reyes-Vargas E; Escobar H; Rudd B; Rockwood AL; Delgado JC; He X; Jensen PE
    Eur J Immunol; 2016 Apr; 46(4):834-45. PubMed ID: 26707565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential.
    Johansen BH; Jensen T; Thorpe CJ; Vartdal F; Thorsby E; Sollid LM
    Immunogenetics; 1996; 45(2):142-50. PubMed ID: 8952964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8.
    Chicz RM; Lane WS; Robinson RA; Trucco M; Strominger JL; Gorga JC
    Int Immunol; 1994 Nov; 6(11):1639-49. PubMed ID: 7865457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
    Ge X; James EA; Reijonen H; Kwok WW
    J Autoimmun; 2011 Mar; 36(2):155-60. PubMed ID: 21257290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally processed peptides from HLA-DQ7 (alpha1*0501-beta1*0301): influence of both alpha and beta chain polymorphism in the HLA-DQ peptide binding specificity.
    Khalil-Daher I; Boisgérault F; Feugeas JP; Tieng V; Toubert A; Charron D
    Eur J Immunol; 1998 Nov; 28(11):3840-9. PubMed ID: 9842927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DQ polymorphisms are highly selective for peptide binding interactions.
    Kwok WW; Nepom GT; Raymond FC
    J Immunol; 1995 Sep; 155(5):2468-76. PubMed ID: 7650377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire.
    van Lummel M; van Veelen PA; Zaldumbide A; de Ru A; Janssen GM; Moustakas AK; Papadopoulos GK; Drijfhout JW; Roep BO; Koning F
    J Biol Chem; 2012 Mar; 287(12):9514-24. PubMed ID: 22184118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing.
    Zhou Z; Reyes-Vargas E; Escobar H; Chang KY; Barker AP; Rockwood AL; Delgado JC; He X; Jensen PE
    Eur J Immunol; 2017 Feb; 47(2):314-326. PubMed ID: 27861808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DQ-binding peptide motifs. 1. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes.
    Matsushita S; Nishi T; Oiso M; Yamaoka K; Yone K; Kanai T; Nishimura Y
    Int Immunol; 1996 May; 8(5):757-64. PubMed ID: 8671664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
    Vartdal F; Johansen BH; Friede T; Thorpe CJ; Stevanović S; Eriksen JE; Sletten K; Thorsby E; Rammensee HG; Sollid LM
    Eur J Immunol; 1996 Nov; 26(11):2764-72. PubMed ID: 8921967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
    Moustakas AK; van de Wal Y; Routsias J; Kooy YM; van Veelen P; Drijfhout JW; Koning F; Papadopoulos GK
    Int Immunol; 2000 Aug; 12(8):1157-66. PubMed ID: 10917890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody reactivity to an Epstein-Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 beta chain. Childhood Diabetes in Finland Study Group.
    Parkkonen P; Hyöty H; Ilonen J; Reijonen H; Ylä-Herttuala S; Leinikki P
    Clin Exp Immunol; 1994 Feb; 95(2):287-93. PubMed ID: 7508347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules.
    Astill TP; Ellis RJ; Arif S; Tree TI; Peakman M
    Diabetologia; 2003 Apr; 46(4):496-503. PubMed ID: 12684749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HLA molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 share an extensive overlap in peptide binding specificity.
    Sidney J; del Guercio MF; Southwood S; Sette A
    J Immunol; 2002 Nov; 169(9):5098-108. PubMed ID: 12391226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes.
    Yu B; Gauthier L; Hausmann DH; Wucherpfennig KW
    Eur J Immunol; 2000 Sep; 30(9):2497-506. PubMed ID: 11009082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules.
    Quarsten H; Paulsen G; Johansen BH; Thorpe CJ; Holm A; Buus S; Sollid LM
    Int Immunol; 1998 Aug; 10(8):1229-36. PubMed ID: 9723710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of HLA-DQ8beta cell peptidome using a computational program and its relationship to autoreactive T cells.
    Chang KY; Unanue ER
    Int Immunol; 2009 Jun; 21(6):705-13. PubMed ID: 19461125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.